%A FENG Yan-Li %T Expression and clinical significance of IMP3 and p16 in cervical carcinoma %0 Journal Article %D 2014 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2014.12.020 %P 946-949 %V 41 %N 12 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9605.shtml} %8 2014-12-24 %X ObjectiveTo detect the expression of insulinlike growth factor Ⅱ mRNAbinding protein 3 (IMP3) and p16 in cervical carcinoma and investigate their clinical significance. MethodsImmunohistochemical Envision method was used to detect the expression of IMP3 and p16 proteins in 67 cases of carcinoma of the uterine cervix, 58 cases of cervical intraepithelial neoplasia (CIN) and 15 cases of normal cervical epithelium. ResultsIMP3 was mainly dedected in the cytoplasm, whose positive expression rate was 85.07%（57/67）in cervical carcinoma, 12.07% (7/58) in CIN (χ2=66.32, P＜0.05) and 0 (0/15) in cervical epithelium (χ2=44.38, P＜0.05). No significance variations of the expression of IMP3 were observed in cervical adenocarcinoma and squamous cell carcinoma (χ2=0.35, P＞0.05). p16 was found both in nucleus and cytoplasm of cervical carcinoma, whose expression rate was 83.58% (56/67), higher than 41.37% (24/58) in CIN (χ2=24.85, P＜0.05) and 0 (0/15) in cervical epithelium (χ2=42.61, P＜0.05). ConclusionExpression of IMP3 and p16 is high in cervical carcinoma, maybe can be used as a potential biomarker of metastasis and progression.